Video Shorts

1:03
Biotech’s Education Mandate
4 days ago
by
Michael Christel(+2 more)

1:07
The Next Generation of Obesity Treatment Challenges
5 days ago
by
Mike Hollan(+1 more)

1:11
Market Movers RX: Pacific Biosciences Leads Gainers
10 days ago
by
Nicholas Jacobus

1:07
The Hidden Cost of Self-Reported Patient Data
12 days ago
by
Mike Hollan(+1 more)

0:48
Why Connecting Talent is the Key to Scaling Business
19 days ago
by
Mike Hollan(+1 more)

1:09
Filling the Gaps in Digital Health and Care Navigation
20 days ago
by
Mike Hollan(+1 more)

1:17
Market Movers RX: Moderna & Roche Top Gainers
24 days ago
by
Nicholas Jacobus

1:12
Why Your Diabetes and Obesity Meds Might Not Be Working
a month ago
by
Mike Hollan(+1 more)

1:18
Exec on Execs: Pharma Pricing's Regulatory Status
a month ago
by
Mike Hollan

0:42
Why Executive Orders Won't Fix Drug Prices
a month ago

1:20
Market Movers RX: West Pharmaceutical Services Leads Gainers
a month ago
by
Nicholas Jacobus

1:10
The Evolution and Future of IBD Treatments
a month ago
by
Mike Hollan(+1 more)

1:41
Exec on Execs: The Changing Data Environment
a month ago
by
Mike Hollan

1:21
Market Movers Rx: Belite Bio Leads Gainers
a month ago
by
Nicholas Jacobus

0:50
Unlocking the Future of Real-World Data & Research
a month ago
by
Mike Hollan(+1 more)

1:42
Exec on Execs: Persistent Unmet Needs
a month ago
by
Mike Hollan

1:18
Pharma 50: The Trends Behind the Numbers
a month ago
by
Michael Christel

1:28
Market Movers RX: Regeneron and McKesson Lead Gainers
a month ago
by
Nicholas Jacobus

0:51
The Secret Equation for AI Trust
2 months ago
by
Mike Hollan(+1 more)

0:41
Why Patients Will Use Peptides Regardless of FDA Status
2 months ago
by
Nicholas Jacobus(+1 more)

1:31
Exec on Execs: Compliance Burdens
2 months ago
by
Mike Hollan

1:21
Market Movers RX: Eli Lilly Shares Drop
2 months ago
by
Nicholas Jacobus

0:54
Why Global Science Innovation is Shifting to Asia
2 months ago
by
Mike Hollan(+1 more)

1:29
Exec on Execs: Identifying the Gaps
2 months ago
by
Mike Hollan

1:22
Market Movers RX: Gilead Sciences Leads Gainers
2 months ago
by
Nicholas Jacobus

0:57
Targeted Resilience: A Smarter Tariff Response
2 months ago
by
Nicholas Jacobus(+1 more)

0:52
The 340B Drug Pricing Secret
2 months ago
by
Mike Hollan(+1 more)

2:23
Exec on Execs: Fixing What's Broken
2 months ago
by
Mike Hollan

1:32
Market Movers RX: Moderna Leads Gainers
2 months ago
by
Nicholas Jacobus

0:55
Why Multiple Databases Are Killing Your Business Efficiency
2 months ago
by
Mike Hollan(+1 more)
Advertisement
Advertisement
Trending on PharmExec
1
The Bubble You Don’t Know You’re In: A Three-Part Series on The Medical Benefit Bubble
2
FDA Approves Enspryng (Satralizumab) for Thyroid Eye Disease
3
EMA Panel Backs Lilly’s Foundayo for Obesity and Type 2 Diabetes in Europe
4
Is Participation in MFN Voluntary?
5
